Merck KGaA-Pfizer to end late-stage ovarian cancer treatment study
Merck KGaA and Pfizer Inc said on Friday they were ending a late-stage study for their drug to treat a form of ovarian cancer in previously untreated patients. The results…
D-Street Buzz: Pharma stocks gain led by Sun Pharma; Titan spikes 4%, RIL most active
The Indian benchmark indices continued to hold steady with the Nifty50 jumping 100 points, trading at 10,879 while the Sensex zoomed 343 points and was trading at 36,148. Nifty Pharma…
Florida biotech billionaire settles SEC stock manipulation case
By Jonathan Stempel NEW YORK: Florida biotechnology billionaire Phillip Frost has agreed to pay $5.52 million to settle U.S. Securities and Exchange Commission civil charges over his alleged role in…
State medical council says no to crosspathy
Recommends that goverment ban rampant prescription of allopathy drugs by doctors of other branches. While the practice of cross prescription of medicines has become a common practice amongst physicians, medical…
Dr Reddy’s launches oral suspension drug in the US market
Drug major Dr Reddy’s Laboratories Thursday announced the launch of Sevelamer Carbonate for oral suspension, used for controlling serum phosphorus in patients with chronic kidney disease on dialysis, in the…
China regulator probes TCM firm after cancer case sparks online furore
SHANGHAI: Authorities in China are investigating a traditional Chinese medicine (TCM) firm linked to the death of a young girl with cancer, after the case was rekindled online and reignited…
India eyes $100 bn FDI in 2 years; Power, airlines and pharma sectors in focus
India will aim to receive USD 100 billion in foreign direct investments in the next two years and special industrial clusters are being created for countries like Japan, South Korea,…
Suven Life gets product patents from Brazil, Eurasia
Suven Life Sciences Thursday said it has been granted a product patent by Brazil and Eurasia each for a new chemical entity (NCE) used in treatment of disorders associated with…
Glimmer of hope: New ‘supercharged’ drug can protect nerve cells that lead to Alzheimer’s
LONDON: Scientists have developed a drug with potential to stop the breakdown of nerves and brain cells that may lead to Alzheimer’s, Parkinson’s and motor neuron disease. Alzheimer’s disease is…
API Sector Faces Double Whammy Of Supply Disruption And Price Hike
The active pharmaceutical ingredient (API) industry is seen to have encountered a double whammy with disruptions in supply and surge in prices impacting finished formulation manufacture in 2018. Going forward,…
